Professional Documents
Culture Documents
1.4 mg% vs <1.4 mg%. Ruilope
634
:
risk is for S
Cr
>1.5 mg% vs 1.5 mg%. Upper limit for SCr was 3.0 mg%. Fried
640
: risk is
for S
Cr
1.5 mg% versus S
Cr
0.9 mg%. Hemmelgarn
642
: risk is for S
Cr
>2.3 mg/dL vs
2.3 mg/dL.
Proteinuria and relative risk for cardiovascular
disease.
Where possible, results presented are from multivariable
analyses. Agewall
650
, Ljungman
647
: Unadjusted results shown.
Data not available to calculate age or multivariable adjusted
risk.
Modification of Comorbidity:
Cardiovascular Disease
Patients with CKD should be considered
highest risk for CVD.
Aggressive intervention and management of
traditional CV risk factors is indicated.
This particularly includes dyslipidemias.
All adults with Stage1-5 CKD should be evaluated
for dyslipidemia.
Fasting lipid profile with total cholesterol, LDL,
HDL and triglycerides, at baseline, and at least
annually.
Management of Dyslipidemia in CKD
Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive
Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel
III). JAMA, 2001, 285;2486-2497.
http://www.kidney.org/professionals/KDOQI/guidelines_lipids/index.htm
Management of Patients with Chronic
Kidney Disease
Blood glucose control
BP Control
ARBs
ACE Inhibitors
Interventions that delay progression
Reduced Functioning and Well-being
Malnutrition
Osteodystrophy
Anemia
Prevention of Uremic Complications
(GFR < 60 cc/min/1.73 m2)
Cardiovascular Disease
Modifcation of Comorbidity
Pre-emptive Transplantation
Kidney Transplant Evaluation
Timely Dialysis Initiation
Timely Dialysis Access Placement
Choice of Dialysis Modality
Education
An "ESRD Clinic"
Preparation for Renal Replacement Therapy
(GRF < 30 cc/min/1.73m2)
Early Detection of CKD
When to Refer!
Consider co-management with a nephrologist if the
clinical action plan cannot be carried out.
Consider subspecialty referral when*:
Unexplained proteinuria (>1gm/day) or microalbumin/Cr
ratio >250mg albumin/gCr
Unexplained macroscopic or microscopic hematuria
Diabetes and macroalbuminuria
Multiple and recurring kidney stones
Rapidly deteriorating kidney function
Difficult to control hypertension
Refer to a nephrologist when GFR <30 mL/min/1.73
m
2
(CKD Stages 4-5)!
Mandatory Referral to Nephrologist guideline, Niagara Health Quality Coalition, NY
Fig 11. Level of GFR at initiation of replacement therapy (USRDS). Data from Obrador et al.
77
Diabetics Medicare Eligible Most should
have started
Preparation for Renal Replacement
Therapy
(GFR < 30cc/min/1.73m
2
)
Referral to a Nephrologist allows:
Early identification of RRT modality.
Evaluation for kidney transplantation with goal of
pre-emptive transplantation.
REMEMBER, in eligible patients transplantation
confers a survival advantage over dialysis!
Identification of social, functional or nutritional
needs.
Preparation for Renal Replacement
Therapy
(GFR < 30cc/min/1.73m
2
)
Close coordination between PCM and
nephrologist allows:
Timely placement of dialysis access
Timely initiation of dialysis
Timely referral for transplant evaluation
with preemptive transplant if possible.
Conclusions
CKD is a public health problem with poor
outcomes and high cost. CKD is
underdiagnosed and undertreated in the U.S.
Early CKD detection and intervention may
increase opportunities for the prevention of
ESRD and of complications of CKD, including
death.
YOU, the PCM, CAN MAKE A Difference!